Moving Branded Statins to Lowest Copay Tier Improves Patient Adherence

BACKGROUND: Statins are efficacious in reducing the risk of major cardiovascular events for both primary and secondary prevention, yet long-term adherence is poor. Their effectiveness could be compromised in actual practice when patients are not adherent to the treatments. Higher copayments have bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shih-Yin, Shah, Sonali N., Lee, Yuan-Chi, Boulanger, Luke, Mardekian, Jack, Kuznik, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437520/
https://www.ncbi.nlm.nih.gov/pubmed/24372458
http://dx.doi.org/10.18553/jmcp.2014.20.1.34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437520/
https://www.ncbi.nlm.nih.gov/pubmed/24372458
http://dx.doi.org/10.18553/jmcp.2014.20.1.34

Ejemplares similares